Universal Flu Vaccine Shows 95% Efficacy in Phase 3 Clinical Trials
A single-shot vaccine targeting conserved influenza proteins provides broad protection against all known flu strains, potentially ending seasonal vaccination.
Dr. Catherine Adams//Apr 20, 2026//8m